FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering - Seite 3

Nachrichtenquelle: Business Wire (engl.)
21.10.2020, 13:30  |  426   |  0   |   

Diesen Artikel teilen
Seite 3 von 2
Wertpapier


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering - Seite 3 FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordinate Voting Shares of the Company …

Community

Nachrichten des Autors

Titel
Chevron Invests in Geothermal Development Company
ChargePoint Becomes the World’s First Publicly Traded Global EV Charging Network
KKR and Rakuten Complete Seiyu Share Purchase from Walmart
Liberty Latin America Reports Fiscal 2020 Results
Logitech Increases Fiscal Year 2021 Outlook, Raises Long-Term Financial Model
PQ Group Holdings Accelerates Transformation: Enters Agreement to Sell Performance Chemicals Business and Acquires Niche Catalyst Activation ...
Spire Global, Inc., a Leading Global Provider of Space-Based Data and Analytics, to Go Public ...
Accenture Acquires Leadership and Talent Consultancy Cirrus to Support C-Suite Transformations
Transgene and BioInvent Have Enrolled First Patient in Phase I/IIa Trial of Novel Oncolytic Virus ...
U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review
Titel
Nickelodeon Establishes Avatar Studios, Brand-New Content Division Devoted to Expanding the World of Avatar: The Last Airbender and The Legend of Korra
Jumia Reports Fourth Quarter and Full Year 2020 Results
Europcar Mobility Group: Successful C. Eur 50 Million Share Capital Increase With Shareholders’ Preferential Subscription ...
Palantir and 3M Expand Relationship to Build Dynamic Supply Chain
Square, Inc. Announces Fourth Quarter and Full Year 2020 Results
AMC Theatres' Statement on the Reopening of Movie Theatres in New York City
EBIX ALERT– Shareholder Rights Firm Labaton Sucharow is Investigating EBIX INC. (NASDAQ: EBIX) for Potential Securities Violations and Breach of Fiduciary Duty
TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, ...
Hasbro Outlines Strategic Growth Drivers at Virtual Investor Event
ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and ...
Titel
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of EHang Holdings Limited (EH) on Behalf of ...
Global cryptocurrency miner Argo Blockchain enters into LOI to Build 200 MW Mining Facility in ...
BevCanna Completes Next Step in Transformative Acquisition of Naturo Group
Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design
Launch of a capital increase with shareholders’ preferential subscription right of approximately ...
BevCanna Announces Receipt of Health Canada Standard Processing License
Organigram Announces Executive Changes
Nickelodeon Establishes Avatar Studios, Brand-New Content Division Devoted to Expanding the World of Avatar: The Last Airbender and The Legend of Korra
ImmunityBio and NantKwest Announce FDA Authorization to Study hAd5 T-Cell COVID-19 Vaccine for ...
Jumia Reports Fourth Quarter and Full Year 2020 Results
Titel
WEX Merchant Partners Offer Fuel Discounts to Truckers
Dolores J. Ennico Nominated to Join RBC Bearings Board of Directors
Cypress Unveils IoT-AdvantEdge Solutions Providing Developers a Trusted Design Path to IoT Edge ...
Halo Labs President Katie Field to Present at the 2020 Virtual Benzinga Cannabis Capital Conference
Halo Announces Results of Annual General Meeting
Halo Provides Operational Update
Halo to Postpone Reporting Interim Financial Results Due to Delays Caused by the COVID-19 Pandemic
Halo Enters Into Second Amended and Restated Convertible Promissory Note For Aggregate Principal ...
Wells Fargo Bank Decreases Prime Rate to 4.25 Percent
Halo Labs Provides Oregon Business Update

Nachrichten zu den Werten

ZeitTitel
11.02.21
FSD Pharma Announces US$20M At-The-Market Offering

COMMUNITY

ZeitTitel
17.02.21
44
FSD Pharma Announces Phase 2 Clinical Trial IND Filing With The FDA to Treat Patients With COVID-19
24.08.20
157
Willkommen bei FSD nach dem RS